Parecoxib concerning safety failed to come back again in 10 years
The Pfizer’s anti-inflammatory drug, ‘parecoxib(product name: dynastat),’ tried to enter the prescription market against its safety and efficacy issues again in 10 years, but finally failed.
The COX-2 inhibitor anti-inflammatory drug, parecoxib is a drug which practically got kicked out of the p...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
